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2008 showed 6 aa substitutions in the 
envelope gene: V129I, L131Q, I170T, 
E203D, M340T, and I380V. Our results 
support the notion that aa positions at 
129 and 131 in the envelope gene are 
critical genetic markers for phylogenet-
ic classifi cation of DENV-2 (7–9).
Notably, residue 131 in the enve-
lope gene is located within a pH-de-
pendent hinge region at the interface 
between domains I and II of the enve-
lope protein. Mutations at this region 
may affect the pH threshold of fusion 
and the process of conformational 
changes (10).
Our results suggest the circulation 
of genetically different DENV-2 in 
Brazil and that these viruses may have 
a role in severity of dengue diseases. 
These fi ndings can help to further un-
derstand the complex dynamic patho-
genic profi le of dengue viruses and 
their circulation in dengue-endemic 
regions.
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Yersinia Species 
Isolated from Bats, 
Germany
To the Editor: Bats are distribut-
ed worldwide and are among the most 
diverse and species-rich mammals on 
earth. They exist in a large variety of 
distinct ecologic niches. Many bat 
species roost near humans, which is of 
particular interest for research on bat-
to-human transmission of potential 
zoonotic pathogens. Moreover, migra-
tory bats could act as long-distance 
vectors for several infectious agents. 
In recent decades, scientifi c interest in 
chiropteran species has markedly in-
creased because bats are known hosts 
to zoonotic agents, such as henipavi-
ruses, Ebola virus, and severe acute 
respiratory syndrome (SARS)–like 
corona viruses (1,2). However, inves-
tigations regarding bacterial patho-
gens with potential for mutual trans-
mission between bats and humans are 
sparse. The effect of bacterial agents 
on individual bats is largely unknown 
and has been neglected in most studies 
published to date (3).
We conducted a broad study 
during 2006–2008 on diseases and 
causes of death in bats among 16 spe-
cies found in Germany.  Two hundred 
deceased bats, collected in differ-
ent geographic regions in Germany 
(southern Bavaria, eastern Lower Sax-
ony, eastern Brandenburg, and Berlin 
greater metropolitan area), were sub-
jected to necropsy and investigated 
by using routine histopathologic 
and bacteriologic methods. During 
necropsy, instruments were dipped in 
70% ethanol and moved into a Bun-
sen burner fl ame after every incision 
to prevent any cross-contamination. 
For bacteriologic examination, tissue 
samples were treated accordingly to 
prevent environmental contamina-
tion. A freshly cut tissue surface was 
plated onto Columbia agar (5% sheep 
blood; Oxoid, Wesel, Germany), 
Gassner agar (Oxoid), and MacCo-
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nkey agar (Oxoid) and incubated at 
37°C for 24–48 hours.
Twenty-fi ve bacterial genera were 
cultured from bats, including 2 known 
human-pathogenic Yersinia spp., i.e., 
Y. pseudotuberculosis and Y. enteroco-
litica. The fi rst Yersinia strain (Y938) 
was cultured from lung, heart, kidney 
(pure cultures), liver, spleen, and in-
testine (mixed cultures) of a greater 
mouse-eared bat (Myotis myotis). This 
isolate was identifi ed as Y. pseudotu-
berculosis by Api 20E (bioMérieux, 
Nürtingen, Germany), Micronaut-E 
(Merlin Diagnostik GmbH, Bornheim-
Hersel, Germany), and 16S rRNA gene 
analysis (Table). The sequence was 
deposited into GenBank under acces-
sion no. FN561631. Further serologic 
characterization by agglutination test 
(Denka Seiken, Tokyo, Japan) and 
multilocus sequence typing (4) identi-
fi ed Y. pseudotuberculosis serogroup 
1, biovar 5, sequence type (ST) 43 in 
all tissue samples investigated. During 
necropsy, severe enlargement of the 
liver and a marked hemoperitoneum 
were seen. Microscopic examination 
showed multifocal severe necrotizing 
hepatitis and splenitis associated with 
numerous intralesional gram-negative 
coccobacilli and a moderate to marked 
interstitial pneumonia. The remaining 
organs, including heart, kidney, and 
intestine, had no pathologic changes.
The second Yersinia strain 
(Y935), Y. enterocolitica, was isolated 
in pure culture from spleen and intes-
tine of a common pipistrelle (Pipist-
rellus pipistrellus) and identifi ed by 
the methods described above (Table). 
The 16S rRNA sequence was depos-
ited into GenBank under accession 
no. FN561632. No bacteria were cul-
tured from any other organ. Based on 
results of an agglutination test (Denka 
Seiken), the isolate was characterized 
as Y. enterocolitica serotype O:6, bio-
var 1A. Necropsy and histopathologic 
examination showed no infl ammatory 
changes, suggesting a subclinical state 
of infection.
Yersiniosis is a bacterial disease 
with a wide distribution and host 
range. Y. pseudotuberculosis and Y. 
enterocolitica are frequently isolated 
from a variety of wild and domestic 
animals (5), but little is known about 
the occurrence of yersiniosis in free-
ranging chiropteran species. Only few 
reports of fatal Y. pseudotuberculosis 
infection in captive fl ying foxes have 
been published (6,7). In Europe, Y. 
pseudotuberculosis strains belong-
ing to serogroup 1 are most common 
and cause most Y. pseudotuberculosis 
infections in humans and animals (5). 
Isolates of ST43 in the multilocus se-
quence typing database (4) came from 
humans, birds, hares, hedgehog, cat, 
dog, and pig in Europe; humans in 
Asia; marsupial in Australia; and deer 
in Australia and New Zealand. We re-
port an isolate from a free-ranging bat 
in Germany. Y. enterocolitica biovar 
1A has been found in a wide range 
of human, animal, and environmental 
sources. Although often considered 
nonpathogenic, this biovar is de-
scribed as an opportunistic pathogen 
(8), and serovar O:6 has been detected 
as the causative agent of ovine placen-
titis and abortion (9).
Transmission of both Yersinia 
species generally occurs after inges-
tion of contaminated food or water. 
All bat species in Germany are insec-
tivorous, and insects can be infected 
with various microbial agents. Inves-
tigations concerning bacteria–insect 
interactions showed that insects may 
carry pathogenic bacteria, including 
Yersinia (10); thus, insects or contami-
nated water are possible sources of 
both species described.
In conclusion, Y. pseudotubercu-
losis and Y. enterocolitica were iso-
lated from 2 bat species in Germany, 
representing evidence of Yersinia spp. 
in free-ranging vespertilionids. His-
topathologic fi ndings of the greater 
mouse-eared bat were consistent with 
those of systemic Y. pseudotubercu-
losis infection, rendering this species 
pathogenic for bats. The common 
pipistrelle was subclinically infected 
with Y. enterocolitica. The role of 
wild animals as reservoir hosts for 
bacterial pathogens such as Yersinia 
spp. is well known, underlining the 
need for biologists and persons han-
dling wildlife to be aware of these 
zoonotic infectious agents.
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Table. Strain typing results of Yersinia spp. isolates from free-ranging bats, Germany* 
Method Y. pseudotuberculosis† Y. enterocolitica‡
Api 20E profile§ 1 0 1 4 1 1 2 1 7 1 1 5 4 7 2 3  1 7 
Micronaut E,¶ % probability 100% Y. pseudotuberculosis 99.77% Y. enterocolitica
16S rRNA gene analysis, % similarity to sequences in GenBank 100% (1,058 bp) to  
Y. pseudotuberculosis YPIII# 
100% (985 bp) to  
Y. enterocolitica strain 280** 
Serologic characterization by agglutination test Serogroup 1, biovar 5 Serotype O:6, biovar 1A 
Multilocus sequence typing††  1 2 1 2 5 2 1 Not determined 
*Y. pseudotuberculosis obtained from lung, heart, kidney, spleen, liver, and intestine; Y. enterocolitica obtained from spleen and intestine. For Y. 
pseudotuberculosis spleen, liver, and intestine samples, isolates were obtained in mixed culture accompanied by colonies of 1–2 nonspecific bacteria. For 
all remaining tissues, Y. pseudotuberculosis and Y. enterocolitica were isolated in pure culture. 
†GenBank accession no. FN561631. 
‡GenBank accession no. FN561632. 
§bioMérieux, Nürtingen, Germany. 
¶Merlin Diagnostik GmbH, Bornheim-Hersel, Germany. 
#GenBank accession no. CP000950. 
**GenBank accession no. FJ641888. 
††Of gene loci adk, argA, aroA, glnA, thrA, tmk, trpE.
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 To the Editor: Human herpes-
virus 8 (HHV-8) is the etiologic agent 
of Kaposi sarcoma. Sequence analy-
sis of the highly variable open read-
ing frame (ORF)–K1 of HHV-8 has 
enabled the identifi cation of 5 main 
molecular subtypes, A–E (1). A and 
C subtypes are prevalent in persons 
in Europe, Mediterranean countries, 
northwestern China, and the United 
States; subtype B, in persons in sub-
Saharan Africa; subtype D, in persons 
in the Pacifi c Islands and Japan (2–6); 
and subtype E, in Native Americans in 
the United States.
Considering that K1 gene poly-
morphisms of HHV-8–infected persons 
refl ect the divergence accumulated dur-
ing the early migrations of modern hu-
mans out of Africa (1), it is tempting to 
put the polymorphisms observed in the 
different subtypes into an evolution-
ary perspective with their geographic 
distribution. It is thought that Native 
Americans infected by subtype E and 
Pacifi c Islanders, including those in-
fected by subtype D in the Japanese ar-
chipelago, originated from a common 
ancestral genetic stock in continental 
Asia. Because Siberia constitutes the 
geographic link between mainland 
Asia, North America, and the Pacifi c 
(online Technical Appendix, www.cdc.
gov/eid/content/16/3/585-Techapp.
pdf), it is likely that the Siberian re-
gion has served as a source or a cor-
ridor of human dispersals to these re-
gions. Thus, we conducted a molecular 
epidemiology HHV-8 survey of the 
Buryat population, a major indigenous 
group in southern Siberia, to gain new 
insights into the origins, possibly com-
mon, of HHV-8 subtypes D and E.
After consent of local authorities 
and participants, we collected 745 hu-
man blood samples in 1995 in 17 med-
icosocial structures (homes for elderly 
persons, veterans of the Russian army, 
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Letters
Letters commenting on recent 
articles as well as letters reporting 
cases, outbreaks, or original re-
search are welcome. Letters com-
menting on articles should contain 
no more than 300 words and 5 
references; they are more likely to 
be published if submitted within 4 
weeks of the original article’s pub-
lication. Letters reporting cases, 
outbreaks, or original research 
should contain no more than 800 
words and 10 references. They 
may have 1 Figure or Table and 
should not be divided into sec-
tions. All letters should contain 
material not previously published 
and include a word count.
